Evidence map›Paper›PMID 31896810›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

PD-L1 expression in anaplastic large cell lymphoma.

Jianping Kong, Surendra Dasari, Andrew L Feldman

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.International journal of molecular sciences · 2024
    Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jianping KongDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Surendra DasariDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. feldman.andrew@mayo.edu.ORCID http://orcid.org/0000-0001-5009-4808
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

TRAINING GRANT IN CLINICAL PHARMACOLOGYT32GM008685 · NIGMS · MAYO CLINIC ROCHESTER · PI Liewei Wang · 1998 to 2026
$8.2M
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell LymphomasR01CA177734 · NCI · MAYO CLINIC ROCHESTER · PI FELDMAN, ANDREW LEWIS · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA177734NIGMS NIH HHS T32 GM008685
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B7-H1 AntigenLymphoma, Large-Cell, AnaplasticHumansReceptor Protein-Tyrosine KinasesSTAT3 Transcription FactorB7-H1 AntigenReceptor Protein-Tyrosine KinasesSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID31896810
PMCPMC7286765
OpenAlexW2996865998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.